HEADER PROTEIN BINDING 09-APR-10 3MIA TITLE CRYSTAL STRUCTURE OF HIV-1 TAT COMPLEXED WITH ATP-BOUND HUMAN P-TEFB COMPND MOL_ID: 1; COMPND 2 MOLECULE: CELL DIVISION PROTEIN KINASE 9; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 1-345, PROTEIN KINASE DOMAIN; COMPND 5 SYNONYM: CYCLIN-DEPENDENT KINASE 9, SERINE/THREONINE-PROTEIN KINASE COMPND 6 PITALRE, CELL DIVISION CYCLE 2-LIKE PROTEIN KINASE 4, C-2K; COMPND 7 EC: 2.7.11.22, 2.7.11.23; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: CYCLIN-T1; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: UNP RESIDUES 1-266; COMPND 13 SYNONYM: CYCLIN-T, CYCT1; COMPND 14 ENGINEERED: YES; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: PROTEIN TAT; COMPND 17 CHAIN: C; COMPND 18 SYNONYM: TRANSACTIVATING REGULATORY PROTEIN; COMPND 19 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CDC2L4, CDK9; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 9 EXPRESSION_SYSTEM_CELL: INSECT CELLS; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PENTR/SD/D-TOPO VECTOR (INVITROGEN SOURCE 12 K2420); SOURCE 13 MOL_ID: 2; SOURCE 14 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 15 ORGANISM_COMMON: HUMAN; SOURCE 16 ORGANISM_TAXID: 9606; SOURCE 17 GENE: CCNT1, CYCLIN T1; SOURCE 18 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 19 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 20 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 21 EXPRESSION_SYSTEM_CELL: INSECT CELLS; SOURCE 22 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 23 EXPRESSION_SYSTEM_PLASMID: PENTR/SD/D-TOPO VECTOR (INVITROGEN SOURCE 24 K2420); SOURCE 25 MOL_ID: 3; SOURCE 26 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; SOURCE 27 ORGANISM_COMMON: HIV-1; SOURCE 28 ORGANISM_TAXID: 11706; SOURCE 29 STRAIN: ISOLATE HXB2 GROUP M SUBTYPE B; SOURCE 30 GENE: TAT; SOURCE 31 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 32 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 33 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 34 EXPRESSION_SYSTEM_CELL: INSECT CELLS; SOURCE 35 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 36 EXPRESSION_SYSTEM_PLASMID: PENTR/SD/D-TOPO VECTOR (INVITROGEN K2420) KEYWDS P-TEFB, CDK9, CYCLIN T1, HIV-1, TAT, PROTEIN BINDING EXPDTA X-RAY DIFFRACTION AUTHOR T.H.TAHIROV,N.D.BABAYEVA,K.VARZAVAND,J.J.COOPER,S.C.SEDORE,D.H.PRICE REVDAT 3 06-SEP-23 3MIA 1 REMARK SEQADV LINK REVDAT 2 23-JUN-10 3MIA 1 JRNL REVDAT 1 09-JUN-10 3MIA 0 JRNL AUTH T.H.TAHIROV,N.D.BABAYEVA,K.VARZAVAND,J.J.COOPER,S.C.SEDORE, JRNL AUTH 2 D.H.PRICE JRNL TITL CRYSTAL STRUCTURE OF HIV-1 TAT COMPLEXED WITH HUMAN P-TEFB. JRNL REF NATURE V. 465 747 2010 JRNL REFN ISSN 0028-0836 JRNL PMID 20535204 JRNL DOI 10.1038/NATURE09131 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.61 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2849681.900 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.4 REMARK 3 NUMBER OF REFLECTIONS : 19001 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.287 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 933 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.19 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2737 REMARK 3 BIN R VALUE (WORKING SET) : 0.2970 REMARK 3 BIN FREE R VALUE : 0.3650 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 158 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.029 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5008 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 27 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.09000 REMARK 3 B22 (A**2) : 0.09000 REMARK 3 B33 (A**2) : -0.19000 REMARK 3 B12 (A**2) : 9.36000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM SIGMAA (A) : 0.47 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.48 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.57 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.880 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.480 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.660 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.810 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.930 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 26.70 REMARK 3 REMARK 3 NCS MODEL : NONE REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : ANP.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER REMARK 3 TOPOLOGY FILE 4 : ION REMARK 3 TOPOLOGY FILE 5 : ANP.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3MIA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-APR-10. REMARK 100 THE DEPOSITION ID IS D_1000058579. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-OCT-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97921 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19980 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 200 DATA REDUNDANCY : 2.700 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 30.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.47900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 3MI9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50 MM HEPES BUFFER (PH 7.5), 4.25-5% REMARK 280 PEG 20,000, 1 MM TCEP, AND 20 MM GLYCYL-GLYCYL-GLYCINE. THE TAT REMARK 280 P-TEFB ATP CRYSTALS WERE OBTAINED BY SOAKING THE TAT P-TEFB REMARK 280 CRYSTALS IN CRYSTALLIZATION SOLUTION WITH 1MM ATP ANALOG AMPPNP REMARK 280 AND 5 MM MAGNESIUM CHLORIDE FOR 40 MIN., VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.79000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 32.39500 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 32.39500 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 64.79000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6170 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29510 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -85.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 LYS A 3 REMARK 465 GLN A 4 REMARK 465 TYR A 5 REMARK 465 ASP A 6 REMARK 465 SER A 7 REMARK 465 ALA A 89 REMARK 465 SER A 90 REMARK 465 PRO A 91 REMARK 465 TYR A 92 REMARK 465 ASN A 93 REMARK 465 ARG A 94 REMARK 465 CYS A 95 REMARK 465 LYS A 96 REMARK 465 PRO A 341 REMARK 465 PRO A 342 REMARK 465 ARG A 343 REMARK 465 ARG A 344 REMARK 465 LYS A 345 REMARK 465 HIS A 346 REMARK 465 HIS A 347 REMARK 465 HIS A 348 REMARK 465 HIS A 349 REMARK 465 HIS A 350 REMARK 465 HIS A 351 REMARK 465 MET B 1 REMARK 465 GLU B 2 REMARK 465 GLY B 3 REMARK 465 GLU B 4 REMARK 465 ARG B 5 REMARK 465 LYS B 6 REMARK 465 LYS B 253 REMARK 465 ARG B 254 REMARK 465 ILE B 255 REMARK 465 TRP B 256 REMARK 465 ASN B 257 REMARK 465 TRP B 258 REMARK 465 ARG B 259 REMARK 465 ALA B 260 REMARK 465 GLU B 262 REMARK 465 ALA B 263 REMARK 465 ALA B 264 REMARK 465 LYS B 265 REMARK 465 LYS B 266 REMARK 465 ARG C 49 REMARK 465 LYS C 50 REMARK 465 LYS C 51 REMARK 465 ARG C 52 REMARK 465 ARG C 53 REMARK 465 GLN C 54 REMARK 465 ARG C 55 REMARK 465 ARG C 56 REMARK 465 ARG C 57 REMARK 465 ALA C 58 REMARK 465 HIS C 59 REMARK 465 GLN C 60 REMARK 465 ASN C 61 REMARK 465 SER C 62 REMARK 465 GLN C 63 REMARK 465 THR C 64 REMARK 465 HIS C 65 REMARK 465 GLN C 66 REMARK 465 ALA C 67 REMARK 465 SER C 68 REMARK 465 LEU C 69 REMARK 465 SER C 70 REMARK 465 LYS C 71 REMARK 465 GLN C 72 REMARK 465 PRO C 73 REMARK 465 THR C 74 REMARK 465 SER C 75 REMARK 465 GLN C 76 REMARK 465 SER C 77 REMARK 465 ARG C 78 REMARK 465 GLY C 79 REMARK 465 ASP C 80 REMARK 465 PRO C 81 REMARK 465 THR C 82 REMARK 465 GLY C 83 REMARK 465 PRO C 84 REMARK 465 LYS C 85 REMARK 465 GLU C 86 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 212 CA - CB - CG ANGL. DEV. = -14.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 10 72.62 -158.73 REMARK 500 CYS A 13 86.45 -152.05 REMARK 500 GLN A 27 72.90 -114.06 REMARK 500 GLU A 32 -78.23 -79.99 REMARK 500 MET A 52 57.97 -142.75 REMARK 500 LYS A 56 -56.59 -167.62 REMARK 500 GLU A 57 31.52 -88.85 REMARK 500 PHE A 59 121.34 -39.11 REMARK 500 VAL A 79 148.65 -37.58 REMARK 500 ASN A 116 89.37 -69.88 REMARK 500 ASN A 143 30.98 -89.05 REMARK 500 ASP A 149 41.51 -170.54 REMARK 500 ASP A 167 74.97 64.58 REMARK 500 ASN A 179 -101.54 -68.97 REMARK 500 SER A 180 -130.75 -84.01 REMARK 500 VAL A 190 127.94 82.03 REMARK 500 ASP A 205 70.38 -114.96 REMARK 500 ARG A 225 19.07 57.51 REMARK 500 SER A 226 151.55 179.61 REMARK 500 PRO A 227 114.10 -39.99 REMARK 500 ASN A 255 7.42 80.76 REMARK 500 LEU A 261 -8.38 -57.48 REMARK 500 LYS A 264 14.44 -57.98 REMARK 500 LEU A 267 90.03 -164.49 REMARK 500 VAL A 275 -71.23 -45.20 REMARK 500 ARG A 284 -70.31 79.95 REMARK 500 SER A 334 -172.05 -175.47 REMARK 500 MET A 335 -71.81 -41.60 REMARK 500 TRP B 12 44.04 -104.79 REMARK 500 LEU B 35 -26.74 -36.28 REMARK 500 SER B 55 167.19 -43.27 REMARK 500 GLN B 97 52.51 -152.95 REMARK 500 LYS B 106 -72.36 -76.93 REMARK 500 HIS B 113 64.15 -151.49 REMARK 500 GLN B 115 -80.74 -59.37 REMARK 500 GLU B 116 -176.64 -49.09 REMARK 500 THR B 121 15.55 -63.22 REMARK 500 SER B 123 171.00 -54.99 REMARK 500 THR B 216 106.97 -15.99 REMARK 500 ASP B 226 137.53 -173.79 REMARK 500 ASN B 250 34.63 -75.31 REMARK 500 ARG B 251 46.46 -151.91 REMARK 500 GLN C 17 120.88 -34.17 REMARK 500 CYS C 27 146.38 178.82 REMARK 500 LYS C 28 -37.43 -32.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 353 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 154 OD1 REMARK 620 2 ASP A 167 OD2 89.7 REMARK 620 3 ANP A 352 O2A 99.2 78.8 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN C 88 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 261 SG REMARK 620 2 CYS C 25 SG 122.4 REMARK 620 3 CYS C 27 SG 154.1 75.2 REMARK 620 4 CYS C 30 SG 105.8 80.4 95.4 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN C 87 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS C 22 SG REMARK 620 2 HIS C 33 ND1 108.8 REMARK 620 3 CYS C 34 SG 102.4 117.2 REMARK 620 4 CYS C 37 SG 90.4 128.8 103.2 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ANP A 352 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 353 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN C 87 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN C 88 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3MI9 RELATED DB: PDB REMARK 900 THE SAME COMPLEX WITHOUT AMPPNP AND MAGNESIUM DBREF 3MIA A 1 345 UNP P50750 CDK9_HUMAN 1 345 DBREF 3MIA B 1 266 UNP O60563 CCNT1_HUMAN 1 266 DBREF 3MIA C 1 86 UNP P04608 TAT_HV1H2 1 86 SEQADV 3MIA HIS A 346 UNP P50750 EXPRESSION TAG SEQADV 3MIA HIS A 347 UNP P50750 EXPRESSION TAG SEQADV 3MIA HIS A 348 UNP P50750 EXPRESSION TAG SEQADV 3MIA HIS A 349 UNP P50750 EXPRESSION TAG SEQADV 3MIA HIS A 350 UNP P50750 EXPRESSION TAG SEQADV 3MIA HIS A 351 UNP P50750 EXPRESSION TAG SEQADV 3MIA SER C 77 UNP P04608 PRO 77 VARIANT SEQRES 1 A 351 MET ALA LYS GLN TYR ASP SER VAL GLU CYS PRO PHE CYS SEQRES 2 A 351 ASP GLU VAL SER LYS TYR GLU LYS LEU ALA LYS ILE GLY SEQRES 3 A 351 GLN GLY THR PHE GLY GLU VAL PHE LYS ALA ARG HIS ARG SEQRES 4 A 351 LYS THR GLY GLN LYS VAL ALA LEU LYS LYS VAL LEU MET SEQRES 5 A 351 GLU ASN GLU LYS GLU GLY PHE PRO ILE THR ALA LEU ARG SEQRES 6 A 351 GLU ILE LYS ILE LEU GLN LEU LEU LYS HIS GLU ASN VAL SEQRES 7 A 351 VAL ASN LEU ILE GLU ILE CYS ARG THR LYS ALA SER PRO SEQRES 8 A 351 TYR ASN ARG CYS LYS GLY SER ILE TYR LEU VAL PHE ASP SEQRES 9 A 351 PHE CYS GLU HIS ASP LEU ALA GLY LEU LEU SER ASN VAL SEQRES 10 A 351 LEU VAL LYS PHE THR LEU SER GLU ILE LYS ARG VAL MET SEQRES 11 A 351 GLN MET LEU LEU ASN GLY LEU TYR TYR ILE HIS ARG ASN SEQRES 12 A 351 LYS ILE LEU HIS ARG ASP MET LYS ALA ALA ASN VAL LEU SEQRES 13 A 351 ILE THR ARG ASP GLY VAL LEU LYS LEU ALA ASP PHE GLY SEQRES 14 A 351 LEU ALA ARG ALA PHE SER LEU ALA LYS ASN SER GLN PRO SEQRES 15 A 351 ASN ARG TYR TPO ASN ARG VAL VAL THR LEU TRP TYR ARG SEQRES 16 A 351 PRO PRO GLU LEU LEU LEU GLY GLU ARG ASP TYR GLY PRO SEQRES 17 A 351 PRO ILE ASP LEU TRP GLY ALA GLY CYS ILE MET ALA GLU SEQRES 18 A 351 MET TRP THR ARG SER PRO ILE MET GLN GLY ASN THR GLU SEQRES 19 A 351 GLN HIS GLN LEU ALA LEU ILE SER GLN LEU CYS GLY SER SEQRES 20 A 351 ILE THR PRO GLU VAL TRP PRO ASN VAL ASP ASN TYR GLU SEQRES 21 A 351 LEU TYR GLU LYS LEU GLU LEU VAL LYS GLY GLN LYS ARG SEQRES 22 A 351 LYS VAL LYS ASP ARG LEU LYS ALA TYR VAL ARG ASP PRO SEQRES 23 A 351 TYR ALA LEU ASP LEU ILE ASP LYS LEU LEU VAL LEU ASP SEQRES 24 A 351 PRO ALA GLN ARG ILE ASP SER ASP ASP ALA LEU ASN HIS SEQRES 25 A 351 ASP PHE PHE TRP SER ASP PRO MET PRO SER ASP LEU LYS SEQRES 26 A 351 GLY MET LEU SER THR HIS LEU THR SER MET PHE GLU TYR SEQRES 27 A 351 LEU ALA PRO PRO ARG ARG LYS HIS HIS HIS HIS HIS HIS SEQRES 1 B 266 MET GLU GLY GLU ARG LYS ASN ASN ASN LYS ARG TRP TYR SEQRES 2 B 266 PHE THR ARG GLU GLN LEU GLU ASN SER PRO SER ARG ARG SEQRES 3 B 266 PHE GLY VAL ASP PRO ASP LYS GLU LEU SER TYR ARG GLN SEQRES 4 B 266 GLN ALA ALA ASN LEU LEU GLN ASP MET GLY GLN ARG LEU SEQRES 5 B 266 ASN VAL SER GLN LEU THR ILE ASN THR ALA ILE VAL TYR SEQRES 6 B 266 MET HIS ARG PHE TYR MET ILE GLN SER PHE THR GLN PHE SEQRES 7 B 266 PRO GLY ASN SER VAL ALA PRO ALA ALA LEU PHE LEU ALA SEQRES 8 B 266 ALA LYS VAL GLU GLU GLN PRO LYS LYS LEU GLU HIS VAL SEQRES 9 B 266 ILE LYS VAL ALA HIS THR CYS LEU HIS PRO GLN GLU SER SEQRES 10 B 266 LEU PRO ASP THR ARG SER GLU ALA TYR LEU GLN GLN VAL SEQRES 11 B 266 GLN ASP LEU VAL ILE LEU GLU SER ILE ILE LEU GLN THR SEQRES 12 B 266 LEU GLY PHE GLU LEU THR ILE ASP HIS PRO HIS THR HIS SEQRES 13 B 266 VAL VAL LYS CYS THR GLN LEU VAL ARG ALA SER LYS ASP SEQRES 14 B 266 LEU ALA GLN THR SER TYR PHE MET ALA THR ASN SER LEU SEQRES 15 B 266 HIS LEU THR THR PHE SER LEU GLN TYR THR PRO PRO VAL SEQRES 16 B 266 VAL ALA CYS VAL CYS ILE HIS LEU ALA CYS LYS TRP SER SEQRES 17 B 266 ASN TRP GLU ILE PRO VAL SER THR ASP GLY LYS HIS TRP SEQRES 18 B 266 TRP GLU TYR VAL ASP ALA THR VAL THR LEU GLU LEU LEU SEQRES 19 B 266 ASP GLU LEU THR HIS GLU PHE LEU GLN ILE LEU GLU LYS SEQRES 20 B 266 THR PRO ASN ARG LEU LYS ARG ILE TRP ASN TRP ARG ALA SEQRES 21 B 266 CYS GLU ALA ALA LYS LYS SEQRES 1 C 86 MET GLU PRO VAL ASP PRO ARG LEU GLU PRO TRP LYS HIS SEQRES 2 C 86 PRO GLY SER GLN PRO LYS THR ALA CYS THR ASN CYS TYR SEQRES 3 C 86 CYS LYS LYS CYS CYS PHE HIS CYS GLN VAL CYS PHE ILE SEQRES 4 C 86 THR LYS ALA LEU GLY ILE SER TYR GLY ARG LYS LYS ARG SEQRES 5 C 86 ARG GLN ARG ARG ARG ALA HIS GLN ASN SER GLN THR HIS SEQRES 6 C 86 GLN ALA SER LEU SER LYS GLN PRO THR SER GLN SER ARG SEQRES 7 C 86 GLY ASP PRO THR GLY PRO LYS GLU MODRES 3MIA TPO A 186 THR PHOSPHOTHREONINE HET TPO A 186 11 HET ANP A 352 31 HET MG A 353 1 HET ZN C 87 1 HET ZN C 88 1 HETNAM TPO PHOSPHOTHREONINE HETNAM ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER HETNAM MG MAGNESIUM ION HETNAM ZN ZINC ION HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO C4 H10 N O6 P FORMUL 4 ANP C10 H17 N6 O12 P3 FORMUL 5 MG MG 2+ FORMUL 6 ZN 2(ZN 2+) FORMUL 8 HOH *27(H2 O) HELIX 1 1 GLU A 15 SER A 17 5 3 HELIX 2 2 PRO A 60 LEU A 73 1 14 HELIX 3 3 LEU A 110 ASN A 116 1 7 HELIX 4 4 THR A 122 ASN A 143 1 22 HELIX 5 5 LYS A 151 ALA A 153 5 3 HELIX 6 6 THR A 191 ARG A 195 5 5 HELIX 7 7 PRO A 196 LEU A 201 1 6 HELIX 8 8 PRO A 208 ARG A 225 1 18 HELIX 9 9 THR A 233 GLY A 246 1 14 HELIX 10 10 ASN A 255 GLU A 263 5 9 HELIX 11 11 LYS A 274 LEU A 279 1 6 HELIX 12 12 LEU A 279 ARG A 284 1 6 HELIX 13 13 ASP A 285 LEU A 296 1 12 HELIX 14 14 ASP A 299 ARG A 303 5 5 HELIX 15 15 ASP A 305 HIS A 312 1 8 HELIX 16 16 ASP A 313 TRP A 316 5 4 HELIX 17 17 LEU A 324 THR A 330 1 7 HELIX 18 18 SER A 334 ALA A 340 1 7 HELIX 19 19 THR B 15 ASN B 21 1 7 HELIX 20 20 SER B 24 GLY B 28 5 5 HELIX 21 21 ASP B 30 LEU B 52 1 23 HELIX 22 22 SER B 55 TYR B 70 1 16 HELIX 23 23 PRO B 79 GLU B 95 1 17 HELIX 24 24 LYS B 100 HIS B 113 1 14 HELIX 25 25 SER B 123 LEU B 144 1 22 HELIX 26 26 HIS B 152 VAL B 164 1 13 HELIX 27 27 SER B 167 THR B 185 1 19 HELIX 28 28 THR B 186 GLN B 190 5 5 HELIX 29 29 THR B 192 SER B 208 1 17 HELIX 30 30 HIS B 220 VAL B 225 5 6 HELIX 31 31 THR B 230 GLU B 246 1 17 HELIX 32 32 LYS B 247 LEU B 252 5 6 HELIX 33 33 GLU C 9 HIS C 13 5 5 HELIX 34 34 CYS C 34 LYS C 41 1 8 SHEET 1 A 5 TYR A 19 LYS A 24 0 SHEET 2 A 5 VAL A 33 HIS A 38 -1 O LYS A 35 N ALA A 23 SHEET 3 A 5 LYS A 44 LYS A 49 -1 O LEU A 47 N PHE A 34 SHEET 4 A 5 SER A 98 ASP A 104 -1 O LEU A 101 N LYS A 48 SHEET 5 A 5 LEU A 81 THR A 87 -1 N ILE A 82 O VAL A 102 SHEET 1 B 3 HIS A 108 ASP A 109 0 SHEET 2 B 3 VAL A 155 ILE A 157 -1 O ILE A 157 N HIS A 108 SHEET 3 B 3 LEU A 163 LEU A 165 -1 O LYS A 164 N LEU A 156 SHEET 1 C 2 ILE A 145 LEU A 146 0 SHEET 2 C 2 ARG A 172 ALA A 173 -1 O ARG A 172 N LEU A 146 SSBOND 1 CYS C 25 CYS C 27 1555 1555 2.82 SSBOND 2 CYS C 25 CYS C 30 1555 1555 3.00 LINK C TYR A 185 N TPO A 186 1555 1555 1.33 LINK C TPO A 186 N ASN A 187 1555 1555 1.33 LINK OD1 ASN A 154 MG MG A 353 1555 1555 1.97 LINK OD2 ASP A 167 MG MG A 353 1555 1555 2.30 LINK O2A ANP A 352 MG MG A 353 1555 1555 2.21 LINK SG CYS B 261 ZN ZN C 88 1555 1555 2.31 LINK SG CYS C 22 ZN ZN C 87 1555 1555 2.31 LINK SG CYS C 25 ZN ZN C 88 1555 1555 2.32 LINK SG CYS C 27 ZN ZN C 88 1555 1555 2.30 LINK SG CYS C 30 ZN ZN C 88 1555 1555 2.32 LINK ND1 HIS C 33 ZN ZN C 87 1555 1555 2.26 LINK SG CYS C 34 ZN ZN C 87 1555 1555 2.31 LINK SG CYS C 37 ZN ZN C 87 1555 1555 2.29 CISPEP 1 ASP A 318 PRO A 319 0 -0.08 SITE 1 AC1 13 GLU A 32 ALA A 46 LYS A 48 ASP A 104 SITE 2 AC1 13 PHE A 105 CYS A 106 ALA A 153 ASN A 154 SITE 3 AC1 13 LEU A 156 ASP A 167 MG A 353 HOH A 376 SITE 4 AC1 13 HOH A 377 SITE 1 AC2 3 ASN A 154 ASP A 167 ANP A 352 SITE 1 AC3 4 CYS C 22 HIS C 33 CYS C 34 CYS C 37 SITE 1 AC4 4 CYS B 261 CYS C 25 CYS C 27 CYS C 30 CRYST1 134.286 134.286 97.185 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007447 0.004299 0.000000 0.00000 SCALE2 0.000000 0.008599 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010290 0.00000